# UNIVERSITY OF ALABAMA AT BIRMINGHAM: 1/2 GLobal trial Of Bromocriptine for PeriPartum CardioMyopathy (GLOBal PPCM)

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF ALABAMA AT BIRMINGHAM |
| Location | BIRMINGHAM, AL |
| Project | 1/2 GLobal trial Of Bromocriptine for PeriPartum CardioMyopathy (GLOBal PPCM) |
| Project number | 3UG3HL177574-01A1SD |
| Mechanism | UG3 |
| Institute | National Heart Lung and Blood Institute |
| Award | $31,320 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-15 to 2033-08-31 |
| UEI | YND4PLMC9AN7 |

## Why this score
- Award of $31,320.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11625554). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.